Atlas Trials

Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women

Clinical trial NCT00961272 · COMPLETED

Trial details

NCT number
NCT00961272
Sponsor
Kristine Patterson, MD
Status
COMPLETED
Study type
OBSERVATIONAL
HIV Infections
Start date
2009-07-01
Primary completion
2010-02-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.